ATB Cormark Capital Markets Keeps Their Buy Rating on SNDL (SNDL)
ATB Cormark Capital Markets analyst Frederico Gomes maintained a Buy rating on SNDL today and set a price target of $3.50.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
According to TipRanks, Gomes is a 2-star analyst with an average return of 0.0% and a 58.14% success rate. Gomes covers the Healthcare sector, focusing on stocks such as Canopy Growth, Organigram Global, and Tilray.
Currently, the analyst consensus on SNDL is a Moderate Buy with an average price target of $4.25.
Based on SNDL’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $252.5 million and a net profit of $9.37 million. In comparison, last year the company earned a revenue of $257.68 million and had a GAAP net loss of $67.14 million
Based on the recent corporate insider activity of 15 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of SNDL in relation to earlier this year.
Read More on SNDL:
Disclaimer & DisclosureReport an Issue
- SNDL Inc. Earnings Call: Cost Cuts Amid Cannabis Strain
- SNDL Posts Softer Q1 2026 Sales but Leans on Strong Cash Position and Cannabis Strategy
- SNDL reports Q1 revenue $195.9M vs. $204.9M last year
- SNDL Posts Q1 2026 Loss as Revenue Slips but Balance Sheet Remains Strong
- SNDL Sets April 29 Date to Report First-Quarter 2026 Results
